International Business News - VRTX http://www.ibtimes.com All articles are copyrighted by IBTimes.com 400 100 http://www.ibtimes.com/ http://www.ibtimes.com/images/top_logo_ibt2_3.gif Among the sector activity stories for Monday, Nov. 3, from AP Financial News: CHICAGO (AP)--Shares of the country's consumer electronics chains climbed Monday after Circuit City Stores Inc. said it was closing about 20 percent of its stores across the country. http://www.ibtimes.com/articles/20081103/sector-roundup-consumer-electronics-apparel.htm Mon, 03 Nov 2008 15:42:19 EST Shares of Vertex Pharmaceuticals Inc. gained ground Monday as analysts looked to the company's developing hepatitis C drug as a potential market leader after viewing updated study data. http://www.ibtimes.com/articles/20081103/sector-snap-vertex-get-boost-from-hep-c-drug.htm Mon, 03 Nov 2008 13:18:48 EST Biotechnology company Vertex Pharmaceuticals Inc. said Monday its third-quarter loss widened as revenue fell and costs rose. The Cambridge, Mass.-based maker of drugs to combat viral diseases reported a loss of $130 million, or 93 cents per share, after posting a loss of $107 million, or 82 cents per share, in the year-ago period. http://www.ibtimes.com/articles/20081027/vertex-3q-loss-widens-as-revenue-drop-23-percent.htm Mon, 27 Oct 2008 18:02:10 EDT Among the stock activity stories for Wednesday, Sept. 24, from AP Financial News: NEW YORK (AP)--Shares of MEMC Electronic Materials Inc., which supplies silicon wafers used in making computer chips and solar cells, jumped Wednesday after several analysts reiterated bullish positions despite the company's revised sales forecast. http://www.ibtimes.com/articles/20080924/movers-roundup-memc-jos-a-bank.htm Wed, 24 Sep 2008 14:13:27 EDT Shares of Vertex Pharmaceuticals Inc. rose Wednesday after the biotechnology company provided details that reaffirmed prior positive study results for its hepatitis C drug candidate telaprevir. http://www.ibtimes.com/articles/20080924/vertex-shares-rise-on-hepatitis-c-drug-detail.htm Wed, 24 Sep 2008 17:44:20 EDT Drug maker Vertex Pharmaceuticals Inc. said Monday it expanded its stock sale, as its underwriter bought 1.1 million shares for $28.7 million. The option takes Vertex's total proceeds to $220 million, as the company has sold approximately 8.6 million shares at $25.50. On Thursday, Vertex said it would sell 7.5 million shares for $191.3 million. The underwriter was not named. http://www.ibtimes.com/articles/20080922/vertex-pharma-will-expand-stock-sale.htm Mon, 22 Sep 2008 10:38:46 EDT Among the stock activity stories for Thursday, Sept. 18, from AP Financial News: CHICAGO (AP)--Shares of Pier 1 Imports Inc. climbed Thursday even after the home decor chain posted a worse-than-expected second-quarter loss and withdrew its previous guidance for 2009. http://www.ibtimes.com/articles/20080918/movers-roundup-pier-1-vertex-pharmaceuticals.htm Thu, 18 Sep 2008 14:29:03 EDT Shares of Vertex Pharmaceuticals Inc. rose Thursday after the drug maker said it will sell 7.5 million shares of new stock to raise cash. The Cambridge, Mass., company said late Wednesday that it would sell the stock, and early Thursday it priced the offering at $25.50 per share, which would allow it to raise $191.3 million. Vertex said it will use the funds to develop its late stage drug candidates for hepatitis C and cystic fibrosis, as well as for general corporate purposes. http://www.ibtimes.com/articles/20080918/vertex-declines-after-announcing-stock-sale.htm Thu, 18 Sep 2008 19:18:16 EDT Vertex Pharmaceuticals Inc. on Thursday priced its public offering of 7.5 million common shares at $25.50 each, for expected proceeds of $191.3 million. http://www.ibtimes.com/articles/20080918/vertex-pharmaceuticals-prices-offering-at-discount.htm Thu, 18 Sep 2008 09:49:29 EDT An Oppenheimer analyst downgraded Vertex Pharmaceuticals Inc. Wednesday, saying the stock should trade around its current levels because the company won't have any significant clinical trial data to report. http://www.ibtimes.com/articles/20080903/ahead-of-the-bell-vertex-downgraded.htm Wed, 03 Sep 2008 09:27:28 EDT Among the stock activity stories for Monday, Aug. 4, from AP Financial News: SIOUX FALLS, S.D. (AP)--Shares of Devon Energy Corp., the largest U.S.-based independent oil and gas producer, fell Monday as oil prices plunged in a massive sell-off. http://www.ibtimes.com/articles/20080804/movers-roundup-devon-energy-vertex-pharma.htm Mon, 04 Aug 2008 14:26:27 EDT Shares of Vertex Pharmaceuticals Inc. fell Monday after Schering-Plough Corp. reported positive data from a trial of a hepatitis C drug, showing it could be a strong competitor to Vertex's candidate telaprevir. http://www.ibtimes.com/articles/20080804/vertex-falls-on-data-for-schering-hepatitis-drug.htm Mon, 04 Aug 2008 18:52:21 EDT Among the earnings stories for Friday, Aug. 1, from AP Financial News: Top stories: http://www.ibtimes.com/articles/20080801/earnings-roundup-british-airways-washington-post.htm Fri, 01 Aug 2008 11:06:24 EDT Vertex Pharmaceuticals Inc. said late Thursday its hepatitis C drug candidate telaprevir was both safe and prompted a response in patients during a midstage study. http://www.ibtimes.com/articles/20080801/vertex-hepatitis-c-drug-meets-study-goal.htm Fri, 01 Aug 2008 09:20:01 EDT Vertex Pharmaceuticals Inc. said late Thursday its second-quarter loss narrowed on a large milestone payment for development of its hepatitis C drug candidate telaprevir. http://www.ibtimes.com/articles/20080801/vertex-narrows-2q-loss-but-misses-forecast.htm Fri, 01 Aug 2008 08:36:09 EDT Infinity Pharmaceuticals Inc. said Tuesday it increased the size of its board of directors to 12 members and promoted two executives. The company named two new members to its board of directors: Martin Babler and Ian F. Smith. Babler is president and chief executive of Talima Therapeutics Inc. a privately held drug-delivery company. Smith is an executive vice president and chief financial officer at Vertex Pharmaceuticals Inc. http://www.ibtimes.com/articles/20080722/infinity-announces-new-board-members-promotions.htm Tue, 22 Jul 2008 17:19:00 EDT The Nasdaq 100 index finished lower on Monday, as investors mulled record-high crude oil prices and shares of Sirius Satellite Radio Inc. posted declines. http://www.ibtimes.com/articles/20080630/nasdaq-100-leaders-and-laggards-siri-ryaay.htm Mon, 30 Jun 2008 17:41:16 EDT The Nasdaq 100 index rose Wednesday after the Federal Reserve left interest rates unchanged and shares of Baidu.com Inc. rose. The index, which includes 100 of the largest nonfinancial securities listed on the Nasdaq Stock Market, gained 30.12 points, or 1.6 percent, to 1,933.86. The broader Nasdaq composite rose 32.98 points, or 1.4 percent, to 2,401.26. http://www.ibtimes.com/articles/20080625/nasdaq-100-leaders-and-laggards-bidu-apol.htm Wed, 25 Jun 2008 16:57:35 EDT The Nasdaq 100 index declined to a lower close on Monday, following a rise in crude oil prices and anticipation of the Federal Reserve's two-day meeting on Tuesday. http://www.ibtimes.com/articles/20080623/nasdaq-100-leaders-and-laggards-uaua-fwlt.htm Mon, 23 Jun 2008 16:56:41 EDT The Nasdaq 100 index rose in midday trading Monday as a regulatory chief's recommendation in favor of a satellite radio tie-up helped lift shares, even as crude oil prices touched a high. http://www.ibtimes.com/articles/20080616/midday-leaders-and-laggards-nasdaq-100.htm Mon, 16 Jun 2008 11:50:34 EDT